Outcome of Board Meeting
This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved Audited Financial Results for the quarter and year ended on 31.03.2017.30-05-2017
30-05-2017
Clarification from Venus Remedies Ltd
The Exchange had sought clarification from Venus Remedies Limited with regards to company's name appearing in the list of 'Tax Defaulters' for default in payment of Income Tax. The link of Income Tax Department :- http://office.incometaxindia.gov.in/administration/Pages/tax-defaulters.aspx In response to the same Venus Remedies Ltd had submitted its reply.22-05-2017
Board Meeting To Be Held On 30.05.2017
This is to inform you that the meeting of Board of Directors is scheduled to be held on Tuesday, 30th May 2017 to inter alia consider and approve Audited Financial Results for the quarter & year ended on 31.03.2017 and any other item with the permission of chair. Further, pursuant to the provisions of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, it has been decided to close the trading window for the...20-05-2017
Updates
Pls find enclosed enclosed herewith disclosure under Regulation 31(1) and 31(2) SEBI (SAST) Regulations, 2011 for pledge of promoter shares.11-05-2017
Updates
Pls find enclosed enclosed herewith disclosure under Regulation 31(1) and 31(2) SEBI (SAST) Regulations, 2011 for pledge of promoter shares.08-05-2017
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd29-04-2017
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd29-04-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Venus Remedies Ltd18-04-2017
Compliance Under Regulation 32(1)Of SEBI (LODR) Regulation, 2015
We hereby, confirm that proceeds from preferential issue has been fully utilized by the Company as per the objects mentioned in the notice of Annual General Meeting dated 29.09.2016. There is no deviation or variation in the utilization of proceeds.15-04-2017
Shareholding for the Period Ended March 31, 2017
Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here15-04-2017